ProQR Therapeutics (PRQR) Notes Payables (2021)
ProQR Therapeutics (PRQR) has disclosed Notes Payables for 1 consecutive years, with $5.5 million as the latest value for Q4 2021.
- Quarterly Notes Payables changed N/A to $5.5 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2021, changed N/A year-over-year, with the annual reading at $5.6 million for FY2021, N/A changed from the prior year.
- Notes Payables hit $5.5 million in Q4 2021 for ProQR Therapeutics.
- In the past five years, Notes Payables ranged from a high of $5.5 million in Q4 2021 to a low of $5.5 million in Q4 2021.